Wuxue People's Hopital Trials

Wuxue People's Hopital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Wang, Min

NCT06305104: Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.

Recruiting

420

RoW

2.5μg/ml EEC, 5μg/ml EEC, 5 unit（U） EC

Chengdu CoenBiotech Co., Ltd, Beijing Chest Hospital, Capital Medical University, Wuhan Institute for Tuberculosis Control, The Public Health Clinical Center of Chengdu, Xuzhou Infectious Disease Hospital, Jiangsu Province Centers for Disease Control and Prevention, Changde First People's Hospital

Tuberculosis

05/24

06/24

NCT05998759: Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Recruiting

296

RoW

Telitacicept, recombinant human B lymphocyte stimulating factor receptor-Fc fusion protein, Recombinant Human B Lymphocyte(RC18), Tai'ai®, Placebo, Placebo control, control

Beijing Hospital, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Peking University People's Hospital, Peking University Third Hospital, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, Wuhan Union Hospital, China, Second Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The Affiliated Hospital of Inner Mongolia Medical University, First Hospital of China Medical University, Shandong Provincial Hospital, Changhai Hospital, RenJi Hospital, Shanxi Bethune Hospital, West China Hospital, Institute of Hematology & Blood Diseases Hospital, China, Tianjin First Central Hospital, Tianjin Medical University General Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The First People's Hospital of Yunnan

Connective Tissue Diseases, Thrombocytopenia

12/25

SKG0106-002, NCT06237777: A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients

Recruiting

RoW

SKG0106 intravitreal injection dose level 1, 2 or 3, SKG0106

Wang Min, Lanyue Biotech (Hangzhou) Co., Ltd.

Diabetic Macular Edema

01/26

NCT03383796: Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Recruiting

N/A

RoW

Three dimensional laparoscopic resection for pCCA, Open resection for pCCA

Tongji Hospital

Cholangiocarcinoma, Perihilar, Surgery

03/21

03/22

NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

Recruiting

N/A

16000

RoW

phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2

Wuhan Union Hospital, China, Peking University First Hospital

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease

12/23

12/24



	Diseases Companies Products Productz Mechanisms of Action Sites